- Rating
- 3(+1)
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 3
- Soundness
- 3
Read review
Paper summary
This paper proposes REACH-breast, a breast-aware vision–language pretraining framework for opportunistic breast cancer diagnosis using routine chest CT. It addresses two key challenges: the scarcity of breast-related descriptions in routine CT reports and the limitations of global image–text alignment in capturing fine-grained, laterality-specific breast abnormalities. Experimental results demonstrate that REACH-breast achieves 89.19% and 83.73% AUC for zero-shot breast malignancy classification on internal and external test sets, respectively. It also outperforms competing methods in bidirectional image–text retrieval, radiology report generation, and BI-RADS risk classification, demonstrating the effectiveness of report enrichment and multi-granularity semantic alignment for opportunistic breast cancer assessment on routine chest CT.
Critical strengths
- The authors introduce BreastCT-12K, containing 12,696 patients with paired chest CT scans, CT reports, and temporally matched breast MRI reports. Enriching CT reports with MRI-derived breast descriptions provides a practical strategy to address insufficient breast-specific language supervision.
- The proposed method is evaluated on multiple tasks, including zero-shot malignancy classification, BI-RADS classification, image–text retrieval, and report generation. The inclusion of an external cohort comprising 5,526 patients from three centers strengthens the empirical evaluation. Ablation studies further investigate the contributions of report enrichment and the proposed alignment modules.
Critical weaknesses
- The proposed BCHA module extracts breast-specific representations using anatomical masks and aligns them with corresponding textual descriptions, which is conceptually similar to anatomy-aware alignment strategies explored in prior works such as fVLM. Likewise, the maximum-similarity matching strategy in SEPA resembles existing fine-grained image–text alignment mechanisms, which has been explored in prior works such as GLoRIA. Although the authors introduce laterality-aware and cross-level alignment, the methodological distinctions from existing approaches are not sufficiently established. More direct technical comparisons and controlled experiments are needed to demonstrate the independent contributions of these designs.
- Insufficiently controlled comparisons on general thoracic disease recognition. Although Appendix D evaluates 16 thoracic findings on CT-RATE, Table 8 mainly relies on previously published results rather than re-evaluating competing methods under identical experimental settings. More importantly, direct comparisons with the closely related fVLM and ViSD-Boost methods are absent. The comparison with the authors' own pretrained baseline also reveals noticeable performance degradation for certain findings, such as arterial wall calcification, where AUC decreases from 88.4% to 71.1%. Therefore, the current evidence is insufficient to establish that breast-specific adaptation adequately preserves general thoracic recognition capabilities.
Questions for authors
Please refer to the weaknesses above
2 comments
We sincerely thank the reviewer for the assessment and constructive questions, which have helped us improve the presentation and completeness of the manuscript.
W1. Technical distinctions and independent contributions of BCHA and SEPA.
We thank the reviewer for highlighting the connections to existing local and regional alignment approaches. The specific distinctions of our method are described below.
a. BCHA versus anatomy-aware alignment.
BCHA extracts breast-region representations from a single pass through the 3D CT encoder and introduces bidirectional cross-level alignment between whole-chest images and bilateral breast text, and between bilateral breast images and global text. Whereas fVLM establishes image–text correspondences at the same level, BCHA explicitly models bidirectional information exchange across spatial scales.
To further assess BCHA's effectiveness, we replace it with an anatomy-aware alignment strategy similar to that used in fVLM. As shown below, BCHA achieves an AUC of 88.01%, compared with 85.55% for the anatomy-aware alignment baseline, supporting the value of its laterality-aware and cross-level design.
Table r1. Internal diagnostic performance of BCHA compared with anatomy-aware alignment (%).
| Model | AUC | ACC | Spec | Sens | F1 | Prec |
|---|---|---|---|---|---|---|
| Baseline | 64.52 | 71.18 | 90.89 | 27.04 | 36.68 | 56.99 |
| Breast CT report | 80.89 | 75.43 | 78.82 | 67.86 | 63.03 | 58.85 |
| BreastCT-12K | 85.20 | 78.35 | 81.89 | 70.41 | 66.75 | 63.45 |
| BreastCT-12K + BCHA | 88.01 | 83.86 | 88.04 | 74.49 | 74.02 | 73.55 |
| BreastCT-12K + anatomy-aware alignment | 85.55 | 79.13 | 82.12 | 72.45 | 68.19 | 64.40 |
b. SEPA versus GLoRIA-style local alignment.
SEPA and GLoRIA share the idea of local image–text alignment, but differ in how they define local correspondences. GLoRIA primarily learns attention-based correspondences between report words and image subregions. SEPA organizes MRI descriptions into sentence-level evidence units, restricts candidate visual patches to the corresponding 3D breast region according to laterality, and computes matching scores in both the evidence-to-patch and patch-to-evidence directions. This design addresses the small size of breast lesions on chest CT and the potential for confusion between the left and right breasts.
Using the same data, backbone, and text settings, we replace SEPA with a GLoRIA-style local loss. As shown below, the GLoRIA-style loss achieves an AUC of 85.80%, compared with 86.37% for SEPA, suggesting that SEPA is better suited to this breast imaging task.
Table r2. Internal diagnostic performance of SEPA compared with a GLoRIA-style local loss (%).
| Model | AUC | ACC | Spec | Sens | F1 | Prec |
|---|---|---|---|---|---|---|
| Baseline | 64.52 | 71.18 | 90.89 | 27.04 | 36.68 | 56.99 |
| Breast CT report | 80.89 | 75.43 | 78.82 | 67.86 | 63.03 | 58.85 |
| BreastCT-12K | 85.20 | 78.35 | 81.89 | 70.41 | 66.75 | 63.45 |
| BreastCT-12K + SEPA | 86.37 | 78.43 | 80.07 | 74.75 | 68.14 | 62.61 |
| BreastCT-12K + GLoRIA-style loss | 85.80 | 77.87 | 80.06 | 72.95 | 67.05 | 62.03 |
W2. Preservation of general thoracic recognition under controlled comparisons.
We thank the reviewer for highlighting the scope of the comparison in Table 8. Results for CT-CLIP and its variants are obtained from the same CT-RATE test set and the same 16 findings, whereas results for BIUD and Merlin are taken from their published papers. Because the evaluation procedures are not fully standardized across methods, we treat these results as published reference values and do not interpret Table 8 as a strictly controlled ranking. fVLM and ViSD-Boost are not included in the original table because they use anatomy-conditioned inference pipelines for thoracic disease recognition; comparing their final scores directly alone cannot measure the extent to which our global representations are retained.
We agree that breast-specific adaptation does not preserve recognition performance equally across all thoracic findings. Appendix D.2 already explicitly reports this variation: AUC for arterial wall calcification decreases substantially, from 88.4% before adaptation to 71.1%. In contrast, AUC improves from 65.0% to 73.2% for lung opacity and from 86.2% to 86.7% for interlobular septal thickening. These finding-specific results indicate that the model retains useful general thoracic representations while improving breast diagnosis, although performance on some findings is substantially affected. Reducing this degradation further is a direction for our future work.
We hope these replies adequately address the concerns. We would be more than happy to conduct further analyses or provide additional clarifications if needed.
Dear Authors,
I noticed that my review has not yet received a response. Could you please address the key questions and concerns raised in my review? Your response would help inform my final evaluation.
Thank you.